|
|
| | (E)-N-hydroxy-4-methoxy-2-(biphenyl-4-yl)cinnamamide Basic information |
| Product Name: | (E)-N-hydroxy-4-methoxy-2-(biphenyl-4-yl)cinnamamide | | Synonyms: | INVIVO-7933;(E)-N-Hydroxy-3-(5-methoxy-[1,1':4',1''-terphenyl]-2-yl)acrylamide;(2E)-N-Hydroxy-3-(5-methoxy[1,1':4',1''-terphenyl]-2-yl)-2-propenamide;2-Propenamide, N-hydroxy-3-(5-methoxy[1,1':4',1''-terphenyl]-2-yl)-, (2E)-;HDAC8-IN-22d;HDAC8 inhibitor 22d;CS-2693;HDAC8 inhibitor 1 | | CAS: | 1417997-93-3 | | MF: | C22H19NO3 | | MW: | 345.39 | | EINECS: | | | Product Categories: | | | Mol File: | 1417997-93-3.mol |  |
| | (E)-N-hydroxy-4-methoxy-2-(biphenyl-4-yl)cinnamamide Chemical Properties |
| density | 1?+-.0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO: soluble | | form | A solid | | pka | 8.76±0.23(Predicted) |
| | (E)-N-hydroxy-4-methoxy-2-(biphenyl-4-yl)cinnamamide Usage And Synthesis |
| Description | HDAC8-IN-1 is an inhibitor of histone deacetylase 8 (HDAC8; IC50 = 27.2 nM). It is selective for HDAC8 over HDAC1-3, -4, -6, -10, and -11 (IC50s = ≥3,000 nM for all). HDAC8-IN-1 is cytotoxic to A549, H1299, and CL1-5 lung cancer cells (IC50s = 7.9, 7.2, and 7 μM, respectively). | | Uses | (2E)-N-Hydroxy-3-(5-methoxy[1,1'':4'',1''''-terphenyl]-2-yl)-2-propenamide, is a HDAC8 inhibitor with an IC50 of 27.2 nM. |
| | (E)-N-hydroxy-4-methoxy-2-(biphenyl-4-yl)cinnamamide Preparation Products And Raw materials |
|